ARTICLE | Clinical News
Vemurafenib: Phase Ib started
April 11, 2011 7:00 AM UTC
Roche began an open-label, dose-escalation, international Phase Ib trial to evaluate oral vemurafenib plus oral GDC-0973 in about 50 patients. Vemurafenib is in Phase III testing for the indication. ...